The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Targeting kidney mesangium by nanoparticles of defined size
Open accessAbstract
Nanoparticles are being investigated for numerous medical applications and are showing potential as an emerging class of carriers for drug delivery. Investigations on how the physicochemical properties (e.g., size, surface charge, shape, and density of targeting ligands) of nanoparticles enable their ability to overcome biological barriers and reach designated cellular destinations in sufficient amounts to elicit biological efficacy are of interest. Despite proven success in nanoparticle accumulation at cellular locations and occurrence of downstream therapeutic effects (e.g., target gene inhibition) in a selected few organs such as tumor and liver, reports on effective delivery of engineered nanoparticles to other organs still remain scarce. Here, we show that nanoparticles of ~75 ± 25-nm diameters target the mesangium of the kidney. These data show the effects of particle diameter on targeting the mesangium of the kidney. Because many diseases originate from this area of the kidney, our findings establish design criteria for constructing nanoparticle-based therapeutics for targeting diseases that involve the mesangium of the kidney.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nanocarriers as an emerging platform for cancer therapy
Peer, D., Karp, J. M., Hong, S., Farokhzad, O. C., Margalit, R., & Langer, R. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.387 · Cited by 8,710
Renal clearance of quantum dots
Soo Choi, H., Liu, W., Misra, P., Tanaka, E., Zimmer, J. P., Itty Ipe, B., Bawendi, M. G., & Frangioni, J. V. (2007) · Nature Biotechnology · doi:10.1038/nbt1340 · Cited by 4,476 · cited 1×
“A celebrated design criterion is the notion of renal clearance (5, 6).”
BackgroundNanoparticle therapeutics: an emerging treatment modality for cancer
Davis, M. E., Chen, Z., & Shin, D. M. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2614 · Cited by 4,233
Self-citationRNAi-mediated gene silencing in non-human primates
Zimmermann, T. S., Lee, A. C. H., Akinc, A., Bramlage, B., Bumcrot, D., Fedoruk, M. N., Harborth, J., Heyes, J. A., Jeffs, L. B., John, M., et al. (2006) · Nature · doi:10.1038/nature04688 · Cited by 1,357
Davis, M. E. (2009) · Molecular Pharmaceutics · doi:10.1021/mp900015y · Cited by 977
Self-citationAcute toxicological effects of copper nanoparticles in vivo
Chen, Z., Meng, H., Xing, G., Chen, C., Zhao, Y., Jia, G., Wang, T., Yuan, H., Ye, C., Zhao, F., et al. (2006) · Toxicology Letters · doi:10.1016/j.toxlet.2005.10.003 · Cited by 965
Bartlett, D. W., Su, H., Hildebrandt, I. J., Weber, W. A., & Davis, M. E. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707461104 · Cited by 803
Self-citationKupffer cells are central in the removal of nanoparticles from the organism
Sadauskas, E., Wallin, H., Stoltenberg, M., Vogel, U., Doering, P., Larsen, A., & Danscher, G. (2007) · Particle and Fibre Toxicology · doi:10.1186/1743-8977-4-10 · Cited by 607
Presence of heparan sulfate in the glomerular basement membrane
Kanwar, Y. S., & Farquhar, M. G. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.3.1303 · Cited by 562
Schipper, M. L., Iyer, G., Koh, A. L., Cheng, Z., Ebenstein, Y., Aharoni, A., Keren, S., Bentolila, L. A., Li, J., Rao, J., et al. (2009) · Small · doi:10.1002/smll.200800003 · Cited by 452
Tissue- and Organ-Selective Biodistribution of NIR Fluorescent Quantum Dots
Choi, H. S., Ipe, B. I., Misra, P., Lee, J. H., Bawendi, M. G., & Frangioni, J. V. (2009) · Nano Letters · doi:10.1021/nl900872r · Cited by 305
Nanoparticle inhalation augments particle-dependent systemic microvascular dysfunction
Nurkiewicz, T. R., Porter, D. W., Hubbs, A. F., Cumpston, J. L., Chen, B. T., Frazer, D. G., & Castranova, V. (2008) · Particle and Fibre Toxicology · doi:10.1186/1743-8977-5-1 · Cited by 281
Rückerl, R., Phipps, R. P., Schneider, A. E., Frampton, M. W., Cyrys, J., Oberdorster, G., Wichmann, H. ‐., & Peters, A. (2007) · Particle and Fibre Toxicology · doi:10.1186/1743-8977-4-1 · Cited by 254
In vitro effects of nanoparticles on renal cells
L'Azou, B., Jorly, J., On, D., Sellier, E., Moisan, F., Fleury‐Feith, J., Cambar, J., Brochard, P., & Ohayon‐Courtès, C. (2008) · Particle and Fibre Toxicology · doi:10.1186/1743-8977-5-22 · Cited by 165
Polymers tethered to curves interfaces: a self-consistent-field analysis
Dan, N. R., & Tirrell, M. (1992) · Macromolecules · doi:10.1021/ma00037a016 · Cited by 136
Podocytes Are Firmly Attached to Glomerular Basement Membrane in Kidneys with Heavy Proteinuria
Lahdenkari, A.-T., Lounatmaa, K., Patrakka, J., Holmberg, C., Wartiovaara, J., Diaeresis], M. K., Koskimies, O., & Jalanko, H. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000139478.03463.d9 · Cited by 121
Sulakhe, P. V., & Dhalla, N. S. (1970) · PubMed · Cited by 46
Tan, M., Wu, X., Jeong, E., Chen, Q., Parker, D. L., & Lu, Z. (2010) · Molecular Pharmaceutics · doi:10.1021/mp100054m · Cited by 43
Cited by
Danaei, M., Dehghankhold, M., Ataei, S., Hasanzadeh Davarani, F., Javanmard, R., Dokhani, A., Khorasani, S., & Mozafari, M. R. (2018) · Pharmaceutics · doi:10.3390/pharmaceutics10020057 · Cited by 4,832
PEGylation as a strategy for improving nanoparticle-based drug and gene delivery
Suk, J. S., Xu, Q., Kim, N., Hanes, J., & Ensign, L. M. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.09.012 · Cited by 4,523
The Effect of Nanoparticle Size on In Vivo Pharmacokinetics and Cellular Interaction
Hoshyar, N., Gray, S., Han, H., & Bao, G. (2016) · Nanomedicine · doi:10.2217/nnm.16.5 · Cited by 1,990
Carbon Nanomaterials for Biological Imaging and Nanomedicinal Therapy
Hong, G., Diao, S., Antaris, A. L., & Dai, H. (2015) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00008 · Cited by 1,394
Targeted drug delivery strategies for precision medicines
Manzari, M. T., Shamay, Y., Kiguchi, H., Rosen, N., Scaltriti, M., & Heller, D. A. (2021) · Nature Reviews Materials · doi:10.1038/s41578-020-00269-6 · Cited by 1,183
Metadata
- Authors
- Choi, C. H. J., Zuckerman, J. E., Webster, P., & Davis, M. E.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2011-04-04
- Volume
- 108
- Issue
- 16
- Pages
- 6656-6661
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2031406458
- Cited by
- 502
- References
- 18
- FWCI
- 8.77
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.